Sulfadoxine
- Generic Name
- Sulfadoxine
- Drug Type
- Small Molecule
- Chemical Formula
- C12H14N4O4S
- CAS Number
- 2447-57-6
- Unique Ingredient Identifier
- 88463U4SM5
- Background
A long acting sulfonamide that is used, usually in combination with other drugs, for respiratory, urinary tract, and malarial infections.
- Indication
Sulfadoxine is used in combination with pyrimethamine for the treatment or prevention of malaria. It can also be used to treat various infections in livestock as well.
Sulfadoxine and pyrimethamine is indicated for the treatment of Plasmodium falciparum malaria in those patients in whom chloroquine resistance is suspected.
- Associated Conditions
- Malaria, Malaria caused by Plasmodium falciparum, Acute, uncomplicated Malaria caused by plasmodium falciparum
Sulfadoxine- Pyrimethamine Versus Weekly Chloroquine for Malaria Prevention in Children With Sickle Cell Anemia
- First Posted Date
- 2006-11-14
- Last Posted Date
- 2009-07-02
- Lead Sponsor
- Makerere University
- Target Recruit Count
- 220
- Registration Number
- NCT00399074
- Locations
- 🇺🇬
Mulago Hospital, Kampala, Central, Uganda
Comparison of Two Strategies for the Delivery of IPTc
- Conditions
- Malaria
- First Posted Date
- 2006-09-14
- Last Posted Date
- 2017-02-10
- Lead Sponsor
- London School of Hygiene and Tropical Medicine
- Target Recruit Count
- 14000
- Registration Number
- NCT00376155
- Locations
- 🇬🇲
MRC Laboratories, Banjul, Gambia
Intermittent Treatment With Sulfadoxine-pyrimethamine for Malaria Control in Infants
- Conditions
- MalariaAnemia
- First Posted Date
- 2005-09-21
- Last Posted Date
- 2010-03-30
- Lead Sponsor
- Bernhard Nocht Institute for Tropical Medicine
- Target Recruit Count
- 1070
- Registration Number
- NCT00206739
- Locations
- 🇬🇭
Kumasi Centre for Collaborative Research in Tropical Medicine, Kumasi, Ashanti Region, Ghana
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.